Cargando…

Critical immunosuppressive effect of MDSC-derived exosomes in the tumor microenvironment

Myeloid-derived suppressor cells (MDSCs) are an indispensable component of the tumor microenvironment (TME). Along with the role of MDSC immunosuppression and antitumor immunity, MDSCs facilitate tumor growth, differentiation, and metastasis in several ways that are yet to be explored. Like any othe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rashid, Mohammad H., Borin, Thaiz F., Ara, Roxan, Piranlioglu, Raziye, Achyut, Bhagelu R., Korkaya, Hasan, Liu, Yutao, Arbab, Ali S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860000/ https://www.ncbi.nlm.nih.gov/pubmed/33469683 http://dx.doi.org/10.3892/or.2021.7936

Ejemplares similares

Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study
por: Ali, Sehar, et al.
Publicado: (2021)

HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model
por: Borin, Thaiz F., et al.
Publicado: (2017)

Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma
por: Arbab, Ali S., et al.
Publicado: (2017)

CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy–Resistant Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2018)

Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis
por: Borin, Thaiz F., et al.
Publicado: (2017)

Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
por: Achyut, Bhagelu R, et al.
Publicado: (2016)

Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development
por: Lee, Eunmi, et al.
Publicado: (2019)

Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models
por: Jain, Meenu, et al.
Publicado: (2017)

Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth
por: Achyut, B. R., et al.
Publicado: (2017)

Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
por: Liu, Junfeng, et al.
Publicado: (2023)

Cancer Therapeutics Following Newton’s Third Law
por: Arbab, Ali S., et al.
Publicado: (2016)

MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
por: Vanhaver, Christophe, et al.
Publicado: (2021)

G-MDSC-derived exosomes mediate the differentiation of M-MDSC into M2 macrophages promoting colitis-to-cancer transition
por: Wang, Yungang, et al.
Publicado: (2023)

Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade
por: Ouzounova, Maria, et al.
Publicado: (2017)

Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma
por: Shankar, Adarsh, et al.
Publicado: (2016)

Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2017)

Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases
por: Elashiry, Mahmoud, et al.
Publicado: (2021)

Exosome-Mediated Immunosuppression in Tumor Microenvironments
por: Xie, Qi-Hui, et al.
Publicado: (2022)

Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model
por: Metzger, Philipp, et al.
Publicado: (2020)

Dendritic cell derived exosomes loaded with immunoregulatory cargo reprogram local immune responses and inhibit degenerative bone disease in vivo
por: Elashiry, Mahmoud, et al.
Publicado: (2020)

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
por: Piranlioglu, Raziye, et al.
Publicado: (2019)

Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer
por: Tian, Xinyu, et al.
Publicado: (2018)

IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
por: Weber, Rebekka, et al.
Publicado: (2020)

CHBP induces stronger immunosuppressive CD127(+) M-MDSC via erythropoietin receptor
por: Li, Jiawei, et al.
Publicado: (2021)

Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients
por: Petrova, Vera, et al.
Publicado: (2023)

GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC
por: Mabrouk, Nesrine, et al.
Publicado: (2023)

Editorial: The Tumor Microenvironment: Recent Advances and Novel Therapeutic Approaches
por: Korkaya, Hasan, et al.
Publicado: (2020)

Therapeutic utility of immunosuppressive TREM2+ macrophages: an important step forward in potentiating the immune checkpoint inhibitors
por: Alkan, Fulya Koksalar, et al.
Publicado: (2020)

Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer
por: Ma, Peiwen, et al.
Publicado: (2019)

Delineating Pro-Angiogenic Myeloid Cells in Cancer Therapy
por: Johnson, Benjamin W., et al.
Publicado: (2018)

Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Differentiation and Immunological Function of MDSC-Derived Dendritic Cells
por: Ding, Zequn, et al.
Publicado: (2022)

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
por: Trabanelli, Sara, et al.
Publicado: (2017)

Tumor derived stress triggers C/EBPβ homologous protein (Chop) expression in myeloid derived suppressor cells (MDSC) and mediates immunosuppressive activity
por: Thevenot, Paul, et al.
Publicado: (2014)

Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy
por: Bullock, Kennady, et al.
Publicado: (2021)

Suppressing MDSC Infiltration in Tumor Microenvironment Serves as an Option for Treating Ovarian Cancer Metastasis
por: Li, Yichen, et al.
Publicado: (2022)

Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes
por: Wang, Dingyi, et al.
Publicado: (2022)

BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma
por: Ishfaq, Mehreen, et al.
Publicado: (2021)

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
por: Bitsch, Rebekka, et al.
Publicado: (2022)

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
por: Umansky, Viktor, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9m00pd4bn54qd9ffrsdu7qjpi4